A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of CEP-33457 in Patients With Systemic Lupus Erythematosus - Celestial 47

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2010
This article has no abstract
Epistemonikos ID: ad91b76e0b838a5ee79b2ae4be75086faf931296
First added on: Aug 22, 2024